Publications:

Identification of pathogenic missense mutations using protein stability predictors.

Scientific Reports

Gerasimavicius, Lukas L; Liu, Xin X; Marsh, Joseph A JA

Publication Date: 2020-09-21

Variant appearance in text: ADA: A71V

PubMed Link: 32958805

Variant Present in the following documents:

• 41598_2020_72404_MOESM2_ESM.xlsx, sheet 3

View BVdb publication page

Computational Analysis of nsSNPs of ADA Gene in Severe Combined Immunodeficiency Using Molecular Modeling and Dynamics Simulation.

Journal Of Immunology Research

Essadssi, Soukaina S; Krami, Al Mehdi AM; Elkhattabi, Lamiae L; Elkarhat, Zouhair Z; Amalou, Ghita G; Abdelghaffar, Houria H; Rouba, Hassan H; Barakat, Abdelhamid A

Publication Date: 2019

Variant appearance in text: ADA: A71V; rs762213530

PubMed Link: 31781678

Variant Present in the following documents:

• 5902391.f1.pdf

View BVdb publication page

Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef.

Antimicrobial Agents And Chemotherapy

Ptak, Roger G RG; Gentry, Brian G BG; Hartman, Tracy L TL; Watson, Karen M KM; Osterling, M Clayton MC; Buckheit, Robert W RW; Townsend, Leroy B LB; Drach, John C JC

Publication Date: 2010-04

Variant appearance in text: ADA: A71V

PubMed Link: 20086149

Variant Present in the following documents:

• Main text

View BVdb publication page

4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro.

Antimicrobial Agents And Chemotherapy

Kodama, E I EI; Kohgo, S S; Kitano, K K; Machida, H H; Gatanaga, H H; Shigeta, S S; Matsuoka, M M; Ohrui, H H; Mitsuya, H H

Publication Date: 2001-05

Variant appearance in text: ADA: A71V

PubMed Link: 11302824

Variant Present in the following documents:

• Main text

View BVdb publication page